BDC Capital Inc. sells Common shares of Clementia Pharmaceuticals Inc.

Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following two offers if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
10-day money back guarantee*
Canadian Insider Ad-Free
$49/ year*
All benefits of basic registration
No 3rd party display ads
10-day money back guarantee*

* Price is subject to applicable taxes. Money back guarantee: For bona fide Ad-Free or Canadian Insider Club subscribers, if you downgrade to Basic or cancel with-in 10 days of first subscribing, we will refund your payment upon request. Immediately after downgrading or cancelling, using the same email that is associated with your account, request a refund via our Contact Us form at the bottom of the page. We will only consider one refund request per household or organization. We cannot accommodate refund requests where an account holder has not provided verifiable address and billing information.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

BDC Capital Inc. sells Common shares of Clementia Pharmaceuticals Inc.

Canada NewsWire

MONTRÉAL, Jan. 11, 2019 /CNW Telbec/ - On January 11, 2019, BDC Capital Inc. ("BDC Capital"), a wholly-owned subsidiary of the Business Development Bank of Canada (the "BDC"), sold 396 common shares (the "Common Shares") in the capital of Clementia Pharmaceuticals Inc. ("Clementia") on the NASDAQ Stock Market (the "Sale") at an average price of US$14.0976 per Common Share (C$18.6920 per Common Share based on the Bank of Canada exchange rate on January 11, 2019), for aggregate gross proceeds to BDC Capital of US$5,582.65 (C$7,402.04 based on the Bank of Canada exchange rate on January 11, 2019).  

Immediately prior to the Sale, BDC beneficially owned or had control or direction over, directly or indirectly, an aggregate of 5,497,607 Common Shares, representing approximately 14.539% of the issued and outstanding Common Shares. As of January 11, 2019, after giving effect to the Sale, BDC beneficially owns or has control or direction over, directly or indirectly, an aggregate of 5,497,211 Common Shares, representing approximately 14.538% of the issued and outstanding Common Shares.

BDC Capital sold the Common Shares as a result of an investment decision and, based on current market conditions, BDC Capital currently intends to dispose of additional Common Shares. BDC Capital may in the future wish to increase or further decrease its shareholdings in Clementia as circumstances warrant, whether in the open market, by privately negotiated agreements, or otherwise. Any transaction that BDC Capital may pursue may be made at any time and from time to time without prior notice and will depend on a variety of factors, including, without limitation, the price and availability of common shares of Clementia, subsequent developments affecting Clementia, its business and prospects, other investment and business opportunities available to BDC Capital, general industry and economic conditions, the securities markets in general, compliance with applicable securities laws and other factors deemed relevant by BDC Capital.

An early warning report relating to this transaction will be filed on SEDAR under Clementia's profile at To obtain a copy of such report, please contact Joanne Lajeunesse, Marketing and Public Affairs, at 514-461-2739. The head office of BDC Capital is located at 5 Place Ville-Marie, Suite 300, Montréal, Québec, H3B 5E7. The BDC is Canada's business development bank, a financial institution dedicated exclusively to entrepreneurs. The head office of Clementia is located at 550-4150 Sainte-Catherine West, Montréal, Québec, H3Z 2Y5.



View original content:

Copyright CNW Group 2019

Comment On!

Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to (via Easy Blurb).